AgNovos Healthcare participates at virtual congress digital O&U 2020 on October 19th – 23rd
AgNovos Healthcare will participate at the virtual congress digital O&U 2020
Keep up to date on AgNovos events and related news
AgNovos Healthcare will participate at the virtual congress digital O&U 2020
The recently issued press release on the FDA's "Breakthrough Designation" for AgNovos' newest investigational product, AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) Kit, has generated a strong of interest in the industry and has been posted on several reputable press portals.
AgNovos Healthcare is pleased to announce that its newest investigational product, AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) Kit, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
AgNovos Healthcare will participate in the “Osteologie Kongress” in Salzburg from March 12th - 14th.
AgNovos Healthcare will participate in the WCO in Barcelona from April 2nd – 5th, 2020.
AgNovos Healthcare will participate in the “Alterstraumatologie Kongress” in Munich from March 19th - 20th where we will exhibit the CE-marked OSSURE LOEP kit.